Therefore, blocking the PD-L1/PD-1 axis restores T-cell function and induces durable tumor remission in cancer patients, especially those with melanoma, non-small-cell lung cancer, renal cell carcinoma, and others3. The gene discussed is PDCD1; the disease is neoplasm.